# Dynamic contrast-enhanced MRI to predict response to vinorelbine–cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial

> Research article (The Lancet, 2016) · cited 10× · AI/ML

**Wikidata**: [openalex:W2545338794](https://www.wikidata.org/wiki/openalex:W2545338794)  
**Source**: https://4ort.xyz/entity/dynamic-contrast-enhanced-mri-to-predict-response-to-vinorelbinecisplatin-alone-or-with-rh-endostatin-in-patients-with-n